Back

Use of CardioQ™ Recommended for All London Hospitals

25 July 2007 - Deltex Medical Group plc ('Deltex Medical' or 'Company'), the UK's leading haemodynamic monitoring company, notes that a major report into the future of healthcare in London has recommended increased use of oesophageal Doppler monitoring.

The Planned Care Clinical Working Group was established to report into the Healthcare for London Review. This review was led by Sir Ara Darzi, who was recently appointed a minister at the Department of Health, with responsibility for conducting the national NHS Next Stage review.

The report draws on treatment methodologies established in Australia and recommends (recommendation 10) that these are established across London:
'When integrating the Melbourne model of treatment into a care package with other (cheap) evidence-based interventions (such as use of perioperative Doppler studies and early feeding/topping up of fluids) quality of care is further improved and length of stay reduced. Thus, seven randomised trials have shown simple use of cheap Doppler technology to reduce length of stay consistently by two to three days in elective intra-abdominal surgery. It is recommended that physician and intensive care management be better integrated with surgical practice, and that appropriate evidence-based care bundles be rapidly established and implemented London-wide.'

The full report can be viewed at http://www.healthcareforlondon.nhs.uk/framework_for_action.asp under the link to 'Planned Care'.

Commenting on the report's recommendation, Deltex Medical's Chief Executive, Andy Hill said:
'The London Planned Care report puts wide-scale use of the CardioQ™ exactly where it should be: at the heart of improving healthcare quality and efficiency.'